Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Meta-Analyses and the Janus Effect.

Braillon A, Naudet F.

Psychother Psychosom. 2019 Nov 12:1. doi: 10.1159/000504201. [Epub ahead of print] No abstract available.

PMID:
31715607
3.

US Food and Drug Administration approval of esketamine and brexanolone.

Cristea IA, Naudet F.

Lancet Psychiatry. 2019 Oct 31. pii: S2215-0366(19)30292-5. doi: 10.1016/S2215-0366(19)30292-5. [Epub ahead of print] No abstract available.

PMID:
31680013
4.

National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism.

Urato AC, Abi-Jaoude E, Abramson J, Alter H, Andrew LB, Antonuccio D, Bero L, Biron P, Boylan LS, Braillon A, Brophy JM, Brownlee S, Cassels A, Cook-Deegan R, Cosgrove L, De Fiore L, Deyo RA, Elshaug A, Farquhar C, Fatovich DM, Fingerman E, Gérvas J, Gøtzsche PC, Gracia R, Heath I, Himmelstein DU, Hoffman JR, Järvinen T, Jureidini J, Kotaska A, Kuehlein T, Lenzer J, Levenstein S, Lexchin J, Mintzes B, Naudet F, Niquette M, Orellana Navarrete LP, Pearson CA, Rail G, Roberts R, Shah N, Sharav V, Siwek J, Topolski S, Tsai AC.

Obstet Gynecol. 2019 Nov;134(5):1115-1117. doi: 10.1097/AOG.0000000000003540. No abstract available.

PMID:
31651818
5.

Nalmefene in alcohol-dependent patients with a high drinking risk: a limited efficacy in reducing alcohol consumption.

Palpacuer C, Braillon A, Naudet F.

Psychiatry Clin Neurosci. 2019 Oct 22. doi: 10.1111/pcn.12946. [Epub ahead of print] No abstract available.

PMID:
31642148
6.

Increase value and reduce waste in research on psychological therapies.

Cristea IA, Naudet F.

Behav Res Ther. 2019 Dec;123:103479. doi: 10.1016/j.brat.2019.103479. Epub 2019 Sep 12.

PMID:
31639527
7.

The YOMEGA non-inferiority trial.

Bergeat D, Sulpice L, Meunier B, Boudjema K, Naudet F.

Lancet. 2019 Oct 19;394(10207):1411-1412. doi: 10.1016/S0140-6736(19)31873-2. No abstract available.

PMID:
31631852
8.

Excess Significance Bias in Repetitive Transcranial Magnetic Stimulation Literature for Neuropsychiatric Disorders.

Amad A, Jardri R, Rousseau C, Larochelle Y, Ioannidis JPA, Naudet F.

Psychother Psychosom. 2019;88(6):363-370. doi: 10.1159/000502805. Epub 2019 Oct 7.

PMID:
31590171
9.

Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis.

Palpacuer C, Hammas K, Duprez R, Laviolle B, Ioannidis JPA, Naudet F.

BMC Med. 2019 Sep 16;17(1):174. doi: 10.1186/s12916-019-1409-3.

10.

Urinary TIMP-2 and MMP-2 are significantly associated with poor bladder compliance in adult patients with spina bifida.

Peyronnet B, Richard C, Bendavid C, Naudet F, Hascoet J, Brochard C, Senal N, Jezequel M, Alimi Q, Khene ZE, Corlu A, Clément B, Siproudhis L, Bouguen G, Kerdraon J, Manunta A, Gamé X.

Neurourol Urodyn. 2019 Nov;38(8):2151-2158. doi: 10.1002/nau.24163. Epub 2019 Sep 4.

PMID:
31486131
11.

Clinical application of mesenchymal stem cells in periodontal regeneration: A systematic review and meta-analysis.

Novello S, Debouche A, Philippe M, Naudet F, Jeanne S.

J Periodontal Res. 2019 Aug 4. doi: 10.1111/jre.12684. [Epub ahead of print] Review.

PMID:
31378933
12.

Open science practices in clinical psychology journals: An audit study.

Nutu D, Gentili C, Naudet F, Cristea IA.

J Abnorm Psychol. 2019 Aug;128(6):510-516. doi: 10.1037/abn0000414.

PMID:
31368730
13.

Digital aripiprazole or digital evergreening? A systematic review of the evidence and its dissemination in the scientific literature and in the media.

Cosgrove L, Cristea IA, Shaughnessy AF, Mintzes B, Naudet F.

BMJ Evid Based Med. 2019 Jul 18. pii: bmjebm-2019-111204. doi: 10.1136/bmjebm-2019-111204. [Epub ahead of print]

PMID:
31320322
14.

Power behind the throne: A clinical trial simulation study evaluating the impact of controllable design factors on the power of antidepressant trials.

Chevance A, Naudet F, Gaillard R, Ravaud P, Porcher R.

Int J Methods Psychiatr Res. 2019 Sep;28(3):e1779. doi: 10.1002/mpr.1779. Epub 2019 Apr 17.

15.

Letter to the Editor: No Baclofen for Alcohol Use Disorders Even More When Liver Disease Is Serious!

Braillon A, Naudet F.

Hepatology. 2019 Jun;69(6):2713. doi: 10.1002/hep.30575. No abstract available.

PMID:
30779442
16.

Repetitive transcranial magnetic stimulation for depression: The non-inferiority extrapolation.

Amad A, Naudet F, Fovet T.

J Affect Disord. 2019 Jul 1;254:124-126. doi: 10.1016/j.jad.2019.01.006. Epub 2019 Jan 5. No abstract available.

17.

Efficacy of acetylleucine in vertigo and dizziness: a systematic review of randomised controlled trials.

Vanderkam P, Blanchard C, Naudet F, Pouchain D, Vaillant Roussel H, Perault-Pochat MC, Jaafari N, Boussageon R.

Eur J Clin Pharmacol. 2019 May;75(5):603-607. doi: 10.1007/s00228-018-02617-6. Epub 2019 Jan 6.

18.

Baclofen and alcohol in France.

Naudet F, Braillon A.

Lancet Psychiatry. 2018 Dec;5(12):961-962. doi: 10.1016/S2215-0366(18)30419-X. Epub 2018 Nov 6. No abstract available.

PMID:
30413392
19.

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs.

Ladanie A, Speich B, Naudet F, Agarwal A, Pereira TV, Sclafani F, Martin-Liberal J, Schmid T, Ewald H, Ioannidis JPA, Bucher HC, Kasenda B, Hemkens LG.

Trials. 2018 Sep 19;19(1):505. doi: 10.1186/s13063-018-2877-z.

20.

Potential Reporting Bias in Neuroimaging Studies of Sex Differences.

David SP, Naudet F, Laude J, Radua J, Fusar-Poli P, Chu I, Stefanick ML, Ioannidis JPA.

Sci Rep. 2018 Apr 17;8(1):6082. doi: 10.1038/s41598-018-23976-1.

21.

Assessing scientists for hiring, promotion, and tenure.

Moher D, Naudet F, Cristea IA, Miedema F, Ioannidis JPA, Goodman SN.

PLoS Biol. 2018 Mar 29;16(3):e2004089. doi: 10.1371/journal.pbio.2004089. eCollection 2018 Mar.

22.

[Junk food antidepressants in primary and secondary care. Letter on the article "Management of first depression or generalized anxiety disorder episode in adults in primary care: A systematic metareview"].

Braillon A, Naudet F.

Presse Med. 2018 Mar;47(3):305-306. doi: 10.1016/j.lpm.2018.02.017. Epub 2018 Mar 13. French. No abstract available.

PMID:
29548767
23.

Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine.

Naudet F, Sakarovitch C, Janiaud P, Cristea I, Fanelli D, Moher D, Ioannidis JPA.

BMJ. 2018 Feb 13;360:k400. doi: 10.1136/bmj.k400. Review.

24.

Equivalence of Psychodynamic Therapy to Other Established Treatments: Limited Supporting Evidence and Clinical Relevance.

Cristea IA, Cuijpers P, Naudet F.

Am J Psychiatry. 2017 Nov 1;174(11):1122-1123. doi: 10.1176/appi.ajp.2017.17050592. No abstract available.

PMID:
29088931
25.

Interpretation of epidemiologic studies very often lacked adequate consideration of confounding.

Hemkens LG, Ewald H, Naudet F, Ladanie A, Shaw JG, Sajeev G, Ioannidis JPA.

J Clin Epidemiol. 2018 Jan;93:94-102. doi: 10.1016/j.jclinepi.2017.09.013. Epub 2017 Sep 21.

PMID:
28943377
26.

Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate.

Palpacuer C, Duprez R, Huneau A, Locher C, Boussageon R, Laviolle B, Naudet F.

Addiction. 2018 Feb;113(2):220-237. doi: 10.1111/add.13974. Epub 2017 Sep 20.

27.

Baclofen and the "first do not harm" motto: a new French paradox?

Braillon A, Naudet F.

Clin Toxicol (Phila). 2018 Apr;56(4):307-308. doi: 10.1080/15563650.2017.1366501. Epub 2017 Aug 21. No abstract available.

PMID:
28826255
28.

Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis.

Leroy A, Naudet F, Vaiva G, Francis A, Thomas P, Amad A.

Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):675-687. doi: 10.1007/s00406-017-0819-5. Epub 2017 Jun 21. Review.

PMID:
28639007
29.

A randomised cross-over study assessing the "blue pyjama syndrome" in major depressive episode.

Delmas H, Batail JM, Falissard B, Robert G, Rangé M, Brousse S, Soulabaille J, Drapier D, Naudet F.

Sci Rep. 2017 Jun 1;7(1):2629. doi: 10.1038/s41598-017-02411-x.

30.

Baclofen and alcohol use disorders: From miracle to mirage.

Braillon A, Naudet F.

Eur Neuropsychopharmacol. 2017 Jul;27(7):691-692. doi: 10.1016/j.euroneuro.2017.05.003. Epub 2017 May 26. No abstract available.

PMID:
28552404
31.

Comments on "What is Wrong With Systematic Reviews and Meta-Analyses: If You Want the Right Answer, Ask the Right Question!"

Carloni R, Naudet F, Watier E, Bertheuil N.

Aesthet Surg J. 2017 Feb;37(2):NP22-NP23. doi: 10.1093/asj/sjw230. Epub 2017 Jan 3. No abstract available.

PMID:
28052907
32.

Impulsive oculomotor action selection in Parkinson's disease.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Robert G, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2017 Jan 27;95:250-258. doi: 10.1016/j.neuropsychologia.2016.12.027. Epub 2016 Dec 28.

33.

Specific and non-specific effects of psychotherapeutic interventions for depression: Results from a meta-analysis of 84 studies.

Palpacuer C, Gallet L, Drapier D, Reymann JM, Falissard B, Naudet F.

J Psychiatr Res. 2017 Apr;87:95-104. doi: 10.1016/j.jpsychires.2016.12.015. Epub 2016 Dec 22. Review.

PMID:
28038336
34.

Nalmefene for alcohol dependence: a NICE decision?

Naudet F, Fitzgerald N, Braillon A.

Lancet Psychiatry. 2016 Dec;3(12):1104-1105. doi: 10.1016/S2215-0366(16)30356-X. No abstract available.

PMID:
27889007
35.

Bias in the reporting of harms in clinical trials of second-generation antidepressants: The tip of the iceberg?

Braillon A, Naudet F.

Eur Neuropsychopharmacol. 2017 Mar;27(3):289-290. doi: 10.1016/j.euroneuro.2016.11.009. Epub 2016 Nov 23.

PMID:
27887861
36.

Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.

Chochina L, Naudet F, Chéhensse C, Manunta A, Damphousse M, Bonan I, Giuliano F.

Sex Med Rev. 2016 Jul;4(3):257-269. doi: 10.1016/j.sxmr.2016.02.005. Epub 2016 Mar 29. Review.

37.

Enhanced Impulsive Action Selection in Middle-Aged Adults-Insights From an Oculomotor Simon Task.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Vérin M, Sauleau P.

Front Aging Neurosci. 2016 Oct 25;8:251. eCollection 2016.

38.

Influence of subthalamic deep-brain stimulation on cognitive action control in incentive context.

Houvenaghel JF, Duprez J, Argaud S, Naudet F, Dondaine T, Robert GH, Drapier S, Haegelen C, Jannin P, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2016 Oct;91:519-530. doi: 10.1016/j.neuropsychologia.2016.09.015. Epub 2016 Sep 21.

39.

Are There Factors Predictive of Postoperative Complications in Circumferential Contouring of the Lower Trunk? A Meta-Analysis.

Carloni R, Naudet F, Chaput B, de Runz A, Herlin C, Girard P, Watier E, Bertheuil N.

Aesthet Surg J. 2016 Nov;36(10):1143-1154. Epub 2016 Jul 8. Review.

PMID:
27402788
40.

Pallidal stimulation in Parkinson's patients with contraindications to subthalamic target: A 3 years follow-up.

Bonenfant J, Drapier S, Houvenaghel JF, Naudet F, Haegelen C, Sauleau P, Vérin M.

Parkinsonism Relat Disord. 2017 Jan;34:20-25. doi: 10.1016/j.parkreldis.2016.10.007. Epub 2016 Oct 11.

41.

Evaluation in alcohol use disorders - insights from the nalmefene experience.

Naudet F, Palpacuer C, Boussageon R, Laviolle B.

BMC Med. 2016 Aug 18;14(1):119. doi: 10.1186/s12916-016-0664-9.

42.

Exploring "psychic transparency" during pregnancy: a mixed-methods approach.

Oriol C, Tordjman S, Dayan J, Poulain P, Rosenblum O, Falissard B, Dindoyal A, Naudet F.

BMC Womens Health. 2016 Aug 12;16(1):55. doi: 10.1186/s12905-016-0332-4.

43.

[Therapeutic efficacy. Between scientific medicine and healthcare medicine].

Boussageon R, Naudet F, Howick J, Falissard B.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 1):700-4. doi: 10.1016/j.lpm.2016.07.005. French. No abstract available.

PMID:
27480673
44.

Influence of promised rewards on conflict resolution in healthy participants and patients with Parkinson's disease.

Houvenaghel JF, Duprez J, Naudet F, Argaud S, Dondaine T, Drapier S, Robert GH, Drapier D, Vérin M, Sauleau P.

J Neurol Sci. 2016 Aug 15;367:38-45. doi: 10.1016/j.jns.2016.05.045. Epub 2016 May 24.

45.
46.

Cost-Effectiveness of Nalmefene: Exaggerated Expectations or Fallacy?

Naudet F, Granger B, Braillon A.

Alcohol Alcohol. 2016 Sep;51(5):623-4. doi: 10.1093/alcalc/agw029. Epub 2016 Jun 3. No abstract available.

PMID:
27261473
47.

Evaluating Cognitive Action Control Using Eye-Movement Analysis: An Oculomotor Adaptation of the Simon Task.

Duprez J, Houvenaghel JF, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Argaud S, Vérin M, Sauleau P.

Front Hum Neurosci. 2016 Mar 2;10:84. doi: 10.3389/fnhum.2016.00084. eCollection 2016.

48.

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Langner-Lemercier S, Houillier C, Soussain C, Ghesquières H, Chinot O, Taillandier L, Soubeyran P, Lamy T, Morschhauser F, Benouaich-Amiel A, Ahle G, Moles-Moreau MP, Moluçon-Chabrot C, Bourquard P, Damaj G, Jardin F, Larrieu D, Gyan E, Gressin R, Jaccard A, Choquet S, Brion A, Casasnovas O, Colin P, Reman O, Tempescul A, Marolleau JP, Fabbro M, Naudet F, Hoang-Xuan K, Houot R.

Neuro Oncol. 2016 Sep;18(9):1297-303. doi: 10.1093/neuonc/now033. Epub 2016 Mar 6.

49.

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials.

Palpacuer C, Laviolle B, Boussageon R, Reymann JM, Bellissant E, Naudet F.

PLoS Med. 2015 Dec 22;12(12):e1001924. doi: 10.1371/journal.pmed.1001924. eCollection 2015 Dec. Review.

50.

Antipsychiatry and the antidepressants debate.

Naudet F, Falissard B.

Lancet Psychiatry. 2014 Aug;1(3):173-4. doi: 10.1016/S2215-0366(14)70296-2. Epub 2014 Aug 5. No abstract available.

PMID:
26360719

Supplemental Content

Loading ...
Support Center